Tagged with pharma

Polpharma SA For years Polpharma has been the market leader in Poland. In many countries the arrival of multinational companies (MNCs) led to the loss of leadership by the historical players to the benefit of MNCs. How has the arrival of GSK, Teva or Sandoz, altered the playing field for the company…

Octapharma Brazil Mr. Mauricio, you’ve mentioned that Brazil is a different kind of market for Octapharma, one strongly based on price, and that because of this it’s hard to add value. Could you delve a bit deeper and elaborate on this point? Before delving into the Brazilian market situation, it is important…

Pharmaceutical Manufacturers Association of Turkey (IEIS) IEIS is an association with dual responsibilities. Promotion of generic usage in turkey and ensuring the sustained development of a local manufacturing industry. Before we look into these two aspects, I would like you to give us your perspective on the future role of the association, in an environment where…

Gelpharma Gelpharma started in 1999 and its main strength lies in manufacturing. Please can you give us a more detailed history of the company and its major milestones since opening? We started over forty years ago from a company called Vitae Laboratorios that for many years had two soft-gel products manufactured…

Hayat Pharmaceutical Industries (HPI) The company was one of the last Jordanian pharma companies to be founded and started production only in 1997… How was Hayat able to establish itself among the leading pharma companies in the country so quickly? What is the key ingredient for the company’s success? We started commercial production and…

Pharma International Co. (PIC) You took over from your father in 2006. What have been the key milestones & achievements in the company’s development since then and how does your approach differentiate from your father’s? I joined Pharma International in 2006. We had already started our production in 2000. Previously we had a British…

The Government Pharmaceutical Organization (G Dr. Witit, when we interviewed your predecessor in 2006, we talked about the vital role and leading position GPO plays in the Thai pharmaceutical industry and the company’s investments in manufacturing facilities to improve access and affordability of drugs. What have been some of the most important milestones since you…

Zuellig Pharma Thailand ‘When markets are inefficient, relationships are important. When markets are more efficient, relationships become less important because the markets become more systematic, professional, and objective in the way they operate,’ said Mr. Zwisler, former CEO of Zuellig Pharma Asia Pacific when we interviewed him in China. At which development stage…

More Pharma Mexico There are about 250 employees and you have regional presence in Latin America. In your view as CEO, can you tell our readers about the biggest growth drivers and challenges in the Mexican pharmaceutical market since then? At More Pharma we believe we are navigating at an ever changing environment.…

Shire Pharmaceuticals Please can you give us a rundown of Shires activities in Mexico in the last four years, and the key achievements and milestones along the way? Shire started operations in Mexico in 2008, a similar story to Brazil. There are very few people working here in Shire Mexico but we…

Octapharma Mexico Please can you give our readers a brief rundown of the major milestones and challenges that you have faced at Octapharma since becoming Managing Director? When Octapharma first came to Mexico in 1994, it was through a distribution agreement with a local company. Six years later in the year 2000…

Hutchison Medipharma You began your career at Pfizer, working your way up the organizational ladder, when suddenly you decided to come to China back in 2001, well before China was on the map for R&D. What drove you to make this choice, to take the risk and come to China? It wasn’t…